603127.SH
昭衍新药
SSE · Healthcare · Medical - Diagnostics & Research · CN
CNY 46.39
−5.85%Next report
Analyst consensus
- Next report date
- Nov 4, 2026
- EPS estimate
- CNY 0.03
- Revenue estimate
- CNY 389.6M
Latest reported
- Last report date
- Aug 28, 2026
- EPS actual
- CNY 0.67
- EPS estimate
- CNY 0.47
- Revenue actual
- CNY 383.9M
- Revenue estimate
- CNY 387.7M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 1
- EPS misses (12Q)
- 0
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +41.7%
- Revenue beats (12Q)
- 0
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 4, 2026